Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.425
Bid: 0.40
Ask: 0.45
Change: 0.00 (0.00%)
Spread: 0.05 (12.50%)
Open: 0.425
High: 0.425
Low: 0.415
Yest. Close: 0.425
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Sareum Holdings PLC - Additional disclosure concerning Michael Owen

Mon, 29th Jul 2019 16:29

RNS Number : 0933H
Sareum Holdings PLC
29 July 2019


29 July 2019


Sareum Holdings plc

("Sareum" or "the Company")

Additional disclosure concerning Michael Owen


Sareum Holdings PLC, the specialist small molecule drug development business, announced on 13 November 2018 the appointment of Michael Owen as a Non-Executive Director of the Company.

It has come to Sareum's attention that whilst his former directorship of BliNK Biomedical SAS ("BliNK") was detailed in that announcement, his former directorship of BliNK's subsidiary Blink Therapeutics Limited during the five years prior to that announcement should also have been included.


For further information, please contact: 

Sareum Holdings plc


Tim Mitchell

01223 497 700

WH Ireland Limited (Nominated Adviser)

Chris Fielding / James Sinclair-Ford

020 7220 1666

Hybridan LLP (Nominated Broker)


Claire Noyce

020 3764 2341

Citigate Dewe Rogerson (Media enquiries)


Shabnam Bashir/ Mark Swallow/ David Dible

020 7638 9571


- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Date   Source Headline
14th Dec 20177:00 amRNSAGM Statement
20th Nov 20177:00 amRNSNotice of AGM and Annual Report & Accounts
18th Sep 201712:00 pmRNSSierra Oncology to host call on Chk1 inhibitor
31st May 20177:00 amRNSSierra Oncology Granted US and EU Patents
25th May 20177:00 amRNSSierra Oncology to Present at ASCO Annual Meeting

Login to your account

Don't have an account? Click here to register.